Uterine artery embolization versus myomectomy: impact on quality of life--results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial

rct OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

Uterine artery embolization and myomectomy both significantly improved quality of life, with UAE offering shorter hospital stays and fewer complications but a higher reintervention rate.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-08 · read from full text

The FUME trial randomized women with symptomatic ultrasound-diagnosed uterine fibroids who wished to preserve their uterus to uterine artery embolization (UAE, n = 82) or myomectomy (n = 81) and compared quality of life at 1 year using a validated questionnaire, along with hospital stay, complications, and reintervention needs. Both groups had significant and equal improvements in quality of life by 1 year, while UAE required a shorter hospitalization (2 vs. 6 days) and had fewer major complications (2.9% vs. 8%, not statistically significant). By 2 years, reinterventions for inadequate symptom control were more frequent after UAE (14.0% vs. 2.7%), and among women who required hysterectomy, half had concomitant adenomyosis missed by ultrasound. This paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: This study was designed to compare quality of life (QoL) outcomes after uterine artery embolization (UAE) or myomectomy. METHODS: Women with symptomatic fibroids diagnosed by ultrasound who wished to preserve their uterus were randomized to myomectomy (n=81) or UAE (n=82). Endpoints at 1 year were QoL measured by a validated questionnaire, hospital stay, rates of complications, and need for reintervention. RESULTS: UAE patients had shorter hospitalization (2 vs. 6 days, p<0.001). By 1 year postintervention, significant and equal improvements in QoL scores had occurred in both groups (myomectomy n=59; UAE n=61). There had been two (2.9%) major complications among UAE versus 6 (8%) among myomectomy patients (not significant). By 2 years, among UAE patients (n=57) there were eight (14.0%) reinterventions for inadequate symptom control compared with one (2.7%) among myomectomy patients (n=37). Half of the women who required hysterectomy had concomitant adenomyosis missed by US. CONCLUSIONS: UAE and myomectomy both result in significant and equal improvements in QoL. UAE allows a shorter hospital stay and fewer major complications but with a higher rate of reintervention.
Full text 8,208 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose This study was designed to compare quality of life (QoL) outcomes after uterine artery embolization (UAE) or myomectomy.

Methods

Women with symptomatic fibroids diagnosed by ultrasound who wished to preserve their uterus were randomized to myomectomy (n = 81) or UAE (n = 82). Endpoints at 1 year were QoL measured by a validated questionnaire, hospital stay, rates of complications, and need for reintervention.

Results

UAE patients had shorter hospitalization (2 vs. 6 days, p < 0.001). By 1 year postintervention, significant and equal improvements in QoL scores had occurred in both groups (myomectomy n = 59; UAE n = 61). There had been two (2.9%) major complications among UAE versus 6 (8%) among myomectomy patients (not significant). By 2 years, among UAE patients (n = 57) there were eight (14.0%) reinterventions for inadequate symptom control compared with one (2.7%) among myomectomy patients (n = 37). Half of the women who required hysterectomy had concomitant adenomyosis missed by US.

Conclusions

UAE and myomectomy both result in significant and equal improvements in QoL. UAE allows a shorter hospital stay and fewer major complications but with a higher rate of reintervention. Similar content being viewed by others

References

Mukhopadhaya N, De Silva C, Manyonda IT (2008) Conventional myomectomy. Best Pract Res Clin Obstet Gynaecol 22(4):677–705 Bratby MJ, Belli AM (2008) Radiological treatment of symptomatic uterine fibroids. Best Pract Res Clin Obstet Gynaecol 22(4):717–734 Office of National Statistics (2009) Birth statistics. Report no.: Series FM1 no. 37. London: Office of National Statistics Olufowobi O, Sharif K, Papaionnon S et al (2004) Are the anticipated benefits of myomectomy achieved in women of reproductive age? A 5-year review of the results at a UK tertiary hospital. J Obstet Gynaecol 24(4):434–440 Vercellini P, Maddalena S, Giorgi OD, Aimi G, Crosignani PG (1998) Abdominal myomectomy for infertility: a comprehensive review. Hum Reprod 13:873–879 Sawin SW, Pilevsky ND, Berlin JA, Barnhart KT (2000) Comparability of perioperative morbidity between abdominal myomectomy and hysterectomy for women with uterine leiomyomas. Am J Obstet Gynecol 183(6):1448–1455 Tulandi T, Murray C, Guralnick M (1993) Adhesion formation and reproductive outcome after myomectomy and second look laparoscopy. Obstet Gynecol 82(2):213–215 Thompson LB, Reed SD, McCrummen BK et al (2006) Leiomyoma characteristics and risk of subsequent surgery after myomectomy. Int J Gynaecol Obstet 95(2):138–143 Pron G, Bennett J, Common A, Wall J, Asch M, Sniderman K (2003) The Ontario Uterine Fibroid Embolization Trial. Part 2. Uterine fibroid reduction and symptom relief after uterine artery embolization for fibroids. Fertil Steril 79:120–127 Pron G, Mocarski E, Bennett J et al (2003) Tolerance, hospital stay, and recovery after uterine artery embolization for fibroids: the Ontario Uterine Fibroid Embolization Trial. J Vasc Interv Radiol 14:1243–1250 Walker WJ, Pelage JP (2002) Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow up. BJOG 109:1262–1272 Siskin GP, Shlansky-Goldberg RD, Goodwin SC et al (2006) A prospective multicenter comparative study between myomectomy and uterine artery embolization with polyvinyl alcohol microspheres: long-term clinical outcomes in patients with symptomatic uterine fibroids. J Vasc Interv Radiol 17:1287–1295 Hirst A, Dutton S, Wu O, Briggs A, Edwards C, Waldenmaier L, Maresh M, Nicholson A, McPherson K (2008) A multi-centre retrospective cohort study comparing the efficacy, safety and cost-effectiveness of hysterectomy and uterine artery embolisation for the treatment of symptomatic uterine fibroids. (HOPEFUL) Health Technol Assess 12(5):1–248 Volkers NA, Hehenkamp WJ, Birnie E, Ankum WM, Reekers JA (2007) Uterine artery embolization versus hysterectomy in the treatment of symptomatic uterine fibroids: 2 years’ outcome from the randomized EMMY trial. Am J Obstet Gynecol 196:519.e1–519.e11 Edwards RD, Moss JG, Lumsden MA et al (2007) Uterine-artery embolization versus surgery for symptomatic uterine fibroids. N Engl J Med 356:360–370 Mara M, Fucikova Z, Maskova J, Kuzel D, Haakova L (2006) Uterine fibroid embolization versus myomectomy in women wishing to preserve fertility: preliminary results of a randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 126:226–233 Matson M, Nicholson A, Belli AM (2000) Anastomoses of the ovarian and uterine arteries: a potential pitfall and cause of failure of uterine embolization. Cardiovasc Intervent Radiol 23(5):393–396 Spies JB, Coyne K, Guaou GN, Boyle D, Skyrnarz-Murphy K, Gonzalves SM et al (2002) The UFS-QOL, a new disease-specific symptom and health-related quality of life questionnaire for leiomyomata. Obstet Gynecol 99(2):290–300 Goodwin SC, Bonilla SM, Sacks D, Reed RA, Spies JB et al (2003) Reporting standards for uterine artery embolization for the treatment of uterine leiomyomata. J Vasc Interv Radiol 14:S467–S476 van der Kooij SM, Hehenkamp WJK, Volkers NA et al (2010) Uterine artery embolization vs hysterectomy in the treatment of symptomatic uterine fibroids: 5-year outcome from the randomized EMMY trial. Am J Obstet Gynecol 203:105.e1–105.e13 Moss JG, Cooper KG, Khaund A et al (2011) Randomized comparison of uterine artery embolization (UAE) with surgical treatment in patients with symptomatic uterine fibroids (REST trial):5-year results. BJOG. doi:10.1111/j.1471-0528 Narayan A, Lee AS, Kuo GP et al (2010) Uterine artery embolization versus abdominal myomectomy: a long-term clinical outcome comparison. J Vasc Interv Radiol 21(7):1011–1017 Bratby MJ, Walker WJ (2009) Uterine artery embolization for symptomatic adenomyosis–mid-term results. Eur J Radiol 70(1):128–132 Kim MD, Kim S, Kim NK et al (2007) Long-term results of uterine artery embolization for symptomatic adenomyosis. Am J Roentgenol 188(1):176–181 Pelage JP, Guaou NG, Jha RC et al (2004) Uterine fibroid tumours: long-term MR imaging outcome after embolization. Radiology 230:803–809 Katsumori T, Kasahara T, Kin Y, Nozaki T (2008) Infarction of uterine fibroids after embolization: relationship between post-procedural enhanced MRI findings and long-term clinical outcomes. Cardiovasc Intervent Radiol 31:66–72 Candiani GB, Fedele L, Parazzini F, Villa L (1991) Risk of recurrence after myomectomy. Br J Obstet Gynaecol 98(4):385–389 Hanafi M (2005) Predictors of leiomyoma recurrence after myomectomy. Obstet Gynecol 105(4):877–881 Seracchioli R, Rossi S, Govoni F, Rossi E, Venturoli S, Bulletti C et al (2000) Fertility and obstetric outcome after laparoscopic myomectomy of large myomata: a randomized comparison with abdominal myomectomy. Hum Reprod 15(12):2663–2668 Griffiths A, D’Angelo A, Amso N (2006) Surgical treatment of fibroids for subfertility. Cochrane Database Syst Rev 3:CD003857 Kolankaya A, Arici A (2006) Myomas and assisted reproductive technologies: when and how to act? Obstet Gynecol Clin N Am 33(1):145–152 Mara M, Maskova J, Fucikova Z et al (2008) Midterm clinical and first reproductive results of a randomized controlled trial comparing uterine fibroid embolization and myomectomy. Cardiovasc Intervent Radiol 31(1):73–85 Homer H, Saridogan E (2010) Uterine artery embolization for fibroids is associated with an increased risk of miscarriage. Fertil Steril 94(1):324–330 Acknowledgments This study did not receive official funding but was supported by soft funds. The authors thank all the women who participated in this trial. Conflict of interest None. Author information Authors and Affiliations Corresponding author Additional information This study was approved by the Wandsworth Research Ethics committee (Ref 01.96.3). Rights and permissions About this article Cite this article Manyonda, I.T., Bratby, M., Horst, J.S. et al. Uterine Artery Embolization versus Myomectomy: Impact on Quality of Life—Results of the FUME (Fibroids of the Uterus: Myomectomy versus Embolization) Trial. Cardiovasc Intervent Radiol 35, 530–536 (2012). https://doi.org/10.1007/s00270-011-0228-5 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00270-011-0228-5

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Leiomyoma Quality of Life Uterine Artery Embolization Uterine Neoplasms Adult Female Humans Hysterectomy Leiomyoma Leiomyoma Leiomyoma Length of Stay Length of Stay Middle Aged Postoperative Complications Postoperative Complications Prospective Studies Retreatment Retreatment Risk Factors

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-06-21T06:12:49.409960+00:00
pubmed
last seen: 2026-05-13T22:16:35.898691+00:00
unpaywall
last seen: 2026-06-21T16:06:39.831647+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine